Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04560270
What this trial is testing

CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer

Who this might be right for
Pancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors
Poitiers University Hospital 69
Early research (Phase 1)Study completedNCT00603356
What this trial is testing

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Not applicableStudy completedNCT00898053
What this trial is testing

Study of Tumor Samples From Patients With Ewing Sarcoma

Who this might be right for
Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Children's Oncology Group 200
Not applicableUnknownNCT00264056
What this trial is testing

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases

Who this might be right for
Advanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Fachklinik Hornheide an der Universität Münster 26
Testing effectiveness (Phase 2)Study completedNCT01010672
What this trial is testing

Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)

Who this might be right for
Sarcoma
Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)UnknownNCT01216839
What this trial is testing

Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Who this might be right for
Refractory or Relapsed RMS and Soft Tissue Sarcomas
Sidnei Epelman 20
Testing effectiveness (Phase 2)UnknownNCT01552239
What this trial is testing

Preoperative Radiotherapy for Sarcomas of the Extremities With Intensity-Modulation, Image-Guidance and Small Safety-margins

Who this might be right for
Soft Tissue Sarcoma of the LimbAJCC Stage II and III
Technical University of Munich 50
Early research (Phase 1)Looking for participantsNCT05880667
What this trial is testing

Adaptive Radiation for Abdominopelvic Metastases

Who this might be right for
Neoplasm - Soft Tissue Pelvis Malignant SecondaryMalignant Neoplasm of Stomach
Fox Chase Cancer Center 30
Not applicableStudy completedNCT03533907
What this trial is testing

Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.

Who this might be right for
Myoma;UterusInfertility, Female
Istituto Clinico Humanitas 20
Testing effectiveness (Phase 2)Study completedNCT00276692
What this trial is testing

Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Cancer and Leukaemia Group 35
Testing effectiveness (Phase 2)Study completedNCT00070109
What this trial is testing

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Soft Tissue Sarcoma+2 more
Children's Oncology Group 50
Testing effectiveness (Phase 2)Looking for participantsNCT06389799
What this trial is testing

A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)

Who this might be right for
Dedifferentiated Liposarcoma
Lund University Hospital 33
Early research (Phase 1)Study completedNCT01014598
What this trial is testing

Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis

Who this might be right for
Metastatic Malignant Neoplasm in the LungStage IIIB Non-Small Cell Lung CancerStage IV Adult Soft Tissue Sarcoma+1 more
Roswell Park Cancer Institute 11
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Not applicableStudy completedNCT00891657
What this trial is testing

Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy

Who this might be right for
FibroidMyomaLeiomyoma
Integra LifeSciences Corporation 15
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT00441467
What this trial is testing

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eleison Pharmaceuticals LLC. 22
Testing effectiveness (Phase 2)Study completedNCT03296553
What this trial is testing

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Who this might be right for
Kaposi SarcomaHuman Immunodeficiency VirusImmune Reconstitution Syndrome
National Institute of Cancerología 40
Early research (Phase 1)Study completedNCT02343172
What this trial is testing

Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma

Who this might be right for
Liposarcoma
Novartis Pharmaceuticals 74
Testing effectiveness (Phase 2)Study completedNCT02116777
What this trial is testing

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more
National Cancer Institute (NCI) 40
Next Page